These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15462098)

  • 1. Urinary guanidinoacetic acid excretion as an indicator of gentamicin nephrotoxicity in rats.
    Kiyatake I; Nakamura T; Koide H
    Ren Fail; 2004 Jul; 26(4):339-44. PubMed ID: 15462098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of guanidinoacetic acid in rats with diabetic nephropathy.
    Kiyatake I; Nakamura T; Koide H
    Ren Fail; 2006; 28(2):177-80. PubMed ID: 16538977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity.
    Morales AI; Buitrago JM; Santiago JM; Fernández-Tagarro M; López-Novoa JM; Pérez-Barriocanal F
    Antioxid Redox Signal; 2002 Dec; 4(6):893-8. PubMed ID: 12573138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of L-arginine on gentamicin-induced nephrotoxicity in rats.
    Başhan İ; Başhan P; Seçilmiş MA; Şingirik E
    Indian J Pharmacol; 2014; 46(6):608-12. PubMed ID: 25538331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanidinoacetic acid (GAA) synthesis in rat tubular suspension as a system for evaluating gentamicin (GM) nephrotoxicity.
    Takeda M; Jung KY; Sekine T; Endou H; Koide H
    Toxicol Lett; 1995 Nov; 81(2-3):85-9. PubMed ID: 8553380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage?
    Nakayama H; Echizen H; Gomi T; Shibuya Y; Nakamura Y; Nakano K; Arashi H; Itai T; Ohnishi S; Tanaka M; Orii T
    Ther Drug Monit; 2009 Feb; 31(1):126-30. PubMed ID: 19125150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy.
    Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A
    Ren Fail; 2014 May; 36(4):534-40. PubMed ID: 24456153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats.
    Beauchamp D; Collin P; Grenier L; LeBrun M; Couture M; Thibault L; Labrecque G; Bergeron MG
    Antimicrob Agents Chemother; 1996 Mar; 40(3):670-6. PubMed ID: 8851591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Protective Role of Glycine max Seed Extract (Soybean Oil) in Drug-Induced Nephrotoxicity in Experimental Rats.
    Ramasamy A; Jothivel N; Das S; Swapna A; Albert AP; Barnwal P; Babu D
    J Diet Suppl; 2018 Sep; 15(5):583-595. PubMed ID: 28956655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelation of urinary and plasma levels of guanidinoacetic acid with alteration in renal activity of glycine amidinotransferase in acute renal failure rats.
    Kuwagaki Y; Sudo J
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):781-4. PubMed ID: 2752493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
    Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical test of renal guanidinoacetic acid metabolism by oral citrulline and creatine loading.
    Kadono K; Yamaguchi T; Tetsutani T; Yasunaga K
    Clin Chim Acta; 1992 Jul; 209(1-2):9-17. PubMed ID: 1395042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.
    Gautier JC; Zhou X; Yang Y; Gury T; Qu Z; Palazzi X; Léonard JF; Slaoui M; Veeranagouda Y; Guizon I; Boitier E; Filali-Ansary A; van den Berg BHJ; Poetz O; Joos T; Zhang T; Wang J; Detilleux P; Li B
    Toxicol Appl Pharmacol; 2016 Jul; 303():1-10. PubMed ID: 27105553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats.
    El-Kashef DH; El-Kenawi AE; Abdel Rahim M; Suddek GM; Salem HA
    Can J Physiol Pharmacol; 2016 Mar; 94(3):278-86. PubMed ID: 26641937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An electron microscopy study of urinary sediment: relationship between myeloid body excretion and gentamicin nephrotoxicity in the rat.
    Mandal AK; Saklayen MG; Taylor CA; Caruso DE; Hillman NM; Bell RD
    Ren Fail; 1991; 13(4):259-66. PubMed ID: 1780494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
    Rodriguez-Barbero A; López-Novoa JM; Arévalo M
    Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of guanidinoacetic acid in isolated renal tubules.
    Takeda M; Kiyatake I; Koide H; Jung KY; Endou H
    Eur J Clin Chem Clin Biochem; 1992 Jun; 30(6):325-31. PubMed ID: 1511066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guanidinoacetic acid in serum, urine and renal cortex from streptozotocin-induced diabetic rats].
    Kiyatake I
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):709-14. PubMed ID: 8084071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methimazole and fish oil treatment on gentamicin nephrotoxicity in rats.
    el Daly ES
    J Pharm Belg; 1997; 52(4):149-56. PubMed ID: 9316341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing low-dose gentamicin-induced kidney injury in rats by analysis of urine.
    Nykjaer A; Schambye H; Pedersen AH; Nielsen H
    J Pharmacol Toxicol Methods; 2009; 60(3):316-20. PubMed ID: 19632345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.